News | Magnetic Resonance Imaging (MRI) | February 18, 2016

ThedaCare Invests in Low-cost MRI Imaging Centers

New partnership supports growing market shift to value-based medicine

Smart Choice MRI, ThedaCare investment, low-cost MRI

February 18, 2016 — ThedaCare, the largest healthcare system in Northeast Wisconsin, is investing $3 million in Smart Choice MRI, the first magnetic resonance imaging provider in the country to offer every MRI for an all-inclusive fee of $600 or less.

ThedaCare is a community-based health system that reinvests in the communities it serves. ThedaCare sees potential for consumers in Smart Choice MRI, while the new partnership creates an opportunity for both companies to learn from each other and use their knowledge and expertise to bring additional value to patients.

“We look for partners who are culturally and collectively a good fit,” said Keith Livingston, ThedaCare senior vice president of systems of care support. “Smart Choice MRI shares our vision to put patients and consumers at the center of the healthcare experience. We sometimes collaborate with competitors in the best interests of consumers. In this case, we admire Smart Choice MRI’s service-orientated, consumer-driven model for imaging, which we can learn from and apply to many aspects of our business. Additionally, this partnership is consistent with our need to learn how to better meet consumers’ needs in the evolving-retail healthcare marketplace.”

ThedaCare doctors will continue to work with patients to determine the most appropriate MRI setting for each individual situation, considering all the factors that impact a patient’s choice for an MRI. These include personal health needs, scheduling, insurance coverage and out-of-pocket costs.

Smart Choice MRI currently has six Wisconsin locations in Milwaukee, Sheboygan, Richfield, Waukesha, Kenosha and Appleton. The company is also scheduled to open at least eight clinics in 2016 — four in the Chicago area by April and four more in the Twin Cities by the second half of the year. Smart Choice MRI will use the $3 million capital investment from ThedaCare to support its expansion.

ThedaCare is the first healthcare system to partner with Smart Choice MRI. As a minority owner of Smart Choice MRI’s overall operation, ThedaCare will have a seat on the Smart Choice MRI board of directors, and anticipates growth on its investment as Smart Choice MRI grows.

For more information: www.smartchoicemri.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
Image by rawpixel from Pixabay

Image by rawpixel from Pixabay 

Feature | Radiology Business | July 18, 2019 | By Stefanie Manack and Judy Zakutny
Approximately 30 percent of a hospital or health system’s profit comes from imaging according, to...
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...